Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia

Yuzuru Kanakura, Yoshitaka Miyakawa, Paul Wilde, Jonathan Smith, Heinrich Achenbach, Shinichiro Okamoto

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythemia'. Together they form a unique fingerprint.

Medicine & Life Sciences